Skip to main content
Top
Published in: Addiction Science & Clinical Practice 1/2021

01-12-2021 | Opioids | Study Protocol

Improving Treatment Together: a protocol for a multi-phase, community-based participatory, and co-design project to improve youth opioid treatment service experiences in British Columbia

Authors: Kirsten Marchand, Corinne Tallon, Christina Katan, Jill Fairbank, Oonagh Fogarty, Katrina Marie Pellatt, Roxanne Turuba, Steve Mathias, Skye Barbic

Published in: Addiction Science & Clinical Practice | Issue 1/2021

Login to get access

Abstract

Background

Opioid use is one of the most critical public health issues as highly potent opioids contribute to rising rates of accidental opioid-related toxicity deaths. This crisis has affected people from all age groups, including youth (ages 15–24) who are in a critical developmental period where the stakes of opioid use are especially high. Efforts to reduce the significant harms of opioid use have focused on the expansion of evidence-based treatments, including medications for opioid use disorder (e.g. buprenorphine). While these treatments are unequivocally life saving, recent evidence suggests that they may not align with youths’ needs. Accordingly, the ‘Improving Treatment Together’ (ITT) project has been designed with the aim to improve youths’ opioid treatment service experiences and outcomes by co-developing, implementing, and measuring youth-centred opioid use treatment service innovations. This manuscript describes the protocol for this multi-phase project.

Methods

The ITT project follows community-based participatory research (CBPR) and strategically integrates co-design processes throughout its four phases. Upon establishing a project partnership between national, provincial and community-based organizations, Phase 1 follows four core elements of human-centred co-design (empathy, needs identification, ideation, prototyping) in nine separate workshops. These workshops will be held in four diverse communities with youth, caregivers and service providers who have accessed or delivered opioid treatment services. Phase 1 will culminate in the co-production of opioid treatment service innovations to be considered by the project’s partners for further co-development, pilot testing, and wider implementation during the remaining phases of the project. Throughout each phase, the project will collect and analyse both qualitative and quantitative research and evaluation data to determine the project’s impact.

Discussion

This protocol provides a detailed description of the ITT project, with an emphasis on the project’s application of co-design and CBPR processes, the planned research and implementation procedures, and the establishment of a unique partnership. To our knowledge, this is one of the first projects to integrate these participatory processes to the design, implementation and measurement of youth-centred opioid treatment services. Embedding these processes throughout each phase of the project will strengthen the relevance and feasibility of the project’s service delivery innovations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. Can Med Assoc J. 2006;174:1589–94.CrossRef Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. Can Med Assoc J. 2006;174:1589–94.CrossRef
2.
go back to reference Strang J, Volkow ND, Degenhardt L, Hickman M, Johnson K, Koob GF, Marshall BDL, Tyndall M, Walsh SL. Opioid use disorder. Nat Rev Dis Primers. 2020;6:3.PubMedCrossRef Strang J, Volkow ND, Degenhardt L, Hickman M, Johnson K, Koob GF, Marshall BDL, Tyndall M, Walsh SL. Opioid use disorder. Nat Rev Dis Primers. 2020;6:3.PubMedCrossRef
3.
go back to reference Han B, Volkow ND, Compton WM, McCance-Katz EF. Reported heroin use, use disorder, and injection among adults in the united states, 2002–2018. JAMA. 2020;323:568–71.PubMedPubMedCentralCrossRef Han B, Volkow ND, Compton WM, McCance-Katz EF. Reported heroin use, use disorder, and injection among adults in the united states, 2002–2018. JAMA. 2020;323:568–71.PubMedPubMedCentralCrossRef
5.
go back to reference Fischer B, Pang M, Tyndall M. The opioid death crisis in canada: crucial lessons for public health. The Lancet Public Health. 2019;4:e81–2.PubMedCrossRef Fischer B, Pang M, Tyndall M. The opioid death crisis in canada: crucial lessons for public health. The Lancet Public Health. 2019;4:e81–2.PubMedCrossRef
6.
go back to reference Belzak L, Halverson J. The opioid crisis in canada: a national perspective. Health Promot Chronic Dis Prev Can. 2018;38:224–33.PubMedCrossRef Belzak L, Halverson J. The opioid crisis in canada: a national perspective. Health Promot Chronic Dis Prev Can. 2018;38:224–33.PubMedCrossRef
7.
go back to reference BC Coroners Service. Illicit drug toxicity deaths in BC Jan 1 2009 to December 31 2019. Ministry of Public Safety and Solicitor General; 2019. BC Coroners Service. Illicit drug toxicity deaths in BC Jan 1 2009 to December 31 2019. Ministry of Public Safety and Solicitor General; 2019.
9.
go back to reference Special Advisory Committee on the Epidemic of Opioid Overdoses. Opioid and stimulant-related harms in Canada. Ottawa: Public Health Agency of Canada; 2021. Special Advisory Committee on the Epidemic of Opioid Overdoses. Opioid and stimulant-related harms in Canada. Ottawa: Public Health Agency of Canada; 2021.
11.
go back to reference Gaither JR, Shabanova V, Leventhal JM. Us national trends in pediatric deaths from prescription and illicit opioids, 1999–2016. JAMA Network Open. 2018;1:e186558.PubMedPubMedCentralCrossRef Gaither JR, Shabanova V, Leventhal JM. Us national trends in pediatric deaths from prescription and illicit opioids, 1999–2016. JAMA Network Open. 2018;1:e186558.PubMedPubMedCentralCrossRef
12.
go back to reference Canadian Institute for Health Information. Opioid-related harms in Canada, December 2018. Ottawa, ON; 2018. Canadian Institute for Health Information. Opioid-related harms in Canada, December 2018. Ottawa, ON; 2018.
13.
go back to reference Chambers RA, Taylor JR, Potenza MN. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry. 2003;160:1041–52.PubMedPubMedCentralCrossRef Chambers RA, Taylor JR, Potenza MN. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry. 2003;160:1041–52.PubMedPubMedCentralCrossRef
14.
go back to reference British Columbia Centre on Substance Use BCMoH, & B.C. Ministry of Mental Health and Addictions. A guideline for the clinical management of opioid use disorder—youth supplement. B.C., Canada; 2018. British Columbia Centre on Substance Use BCMoH, & B.C. Ministry of Mental Health and Addictions. A guideline for the clinical management of opioid use disorder—youth supplement. B.C., Canada; 2018.
16.
go back to reference Arnett JJ. The developmental context of substance use in emerging adulthood. J Drug Issues. 2005;35:235–54.CrossRef Arnett JJ. The developmental context of substance use in emerging adulthood. J Drug Issues. 2005;35:235–54.CrossRef
17.
go back to reference Jenkins EK, Slemon A, Haines-Saah RJ. Developing harm reduction in the context of youth substance use: Insights from a multi-site qualitative analysis of young people’s harm minimization strategies. Harm Reduct J. 2017;14:53.PubMedPubMedCentralCrossRef Jenkins EK, Slemon A, Haines-Saah RJ. Developing harm reduction in the context of youth substance use: Insights from a multi-site qualitative analysis of young people’s harm minimization strategies. Harm Reduct J. 2017;14:53.PubMedPubMedCentralCrossRef
18.
go back to reference Voepel-Lewis T, Boyd CJ, McCabe SE, Zikmund-Fisher BJ, Malviya S, Grant J, Weber M, Tait AR. Deliberative prescription opioid misuse among adolescents andemerging adults: opportunities for targeted interventions. J Adolesc Health. 2018;63:594–600.PubMedPubMedCentralCrossRef Voepel-Lewis T, Boyd CJ, McCabe SE, Zikmund-Fisher BJ, Malviya S, Grant J, Weber M, Tait AR. Deliberative prescription opioid misuse among adolescents andemerging adults: opportunities for targeted interventions. J Adolesc Health. 2018;63:594–600.PubMedPubMedCentralCrossRef
19.
go back to reference Monico LB, Ludwig A, Lertch E, Dionne R, Fishman M, Schwartz RP, Mitchell SG. Opioid overdose experiences in a sample of us adolescents and young adults: a thematic analysis. Addiction. 2021;116:865–73.PubMedCrossRef Monico LB, Ludwig A, Lertch E, Dionne R, Fishman M, Schwartz RP, Mitchell SG. Opioid overdose experiences in a sample of us adolescents and young adults: a thematic analysis. Addiction. 2021;116:865–73.PubMedCrossRef
20.
go back to reference McCabe SE, West BT, Morales M, Cranford JA, Boyd CJ. Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study. Addiction. 2007;102:1920–30.PubMedPubMedCentralCrossRef McCabe SE, West BT, Morales M, Cranford JA, Boyd CJ. Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study. Addiction. 2007;102:1920–30.PubMedPubMedCentralCrossRef
21.
go back to reference Chen CY, Storr CL, Anthony JC. Early-onset drug use and risk for drug dependence problems. Addict Behav. 2009;34:319–22.PubMedCrossRef Chen CY, Storr CL, Anthony JC. Early-onset drug use and risk for drug dependence problems. Addict Behav. 2009;34:319–22.PubMedCrossRef
22.
go back to reference Cerdá M, Santaella J, Marshall BD, Kim JH, Martins SS. Nonmedical prescription opioid use in childhood and early adolescence predicts transitions to heroin use in young adulthood: A national study. J Pediatr. 2015;167:605–12.PubMedPubMedCentralCrossRef Cerdá M, Santaella J, Marshall BD, Kim JH, Martins SS. Nonmedical prescription opioid use in childhood and early adolescence predicts transitions to heroin use in young adulthood: A national study. J Pediatr. 2015;167:605–12.PubMedPubMedCentralCrossRef
23.
go back to reference American Academy of Pediatrics. Medication-assisted treatment of adolescents with opioid use disorders. Pediatrics. 2016;138:e20161893.CrossRef American Academy of Pediatrics. Medication-assisted treatment of adolescents with opioid use disorders. Pediatrics. 2016;138:e20161893.CrossRef
25.
go back to reference The Society for Adolescent Health and Medicine. Medication for adolescents and young adults with opioid use disorder. J Adolesc Health. 2021;68:632–6.CrossRef The Society for Adolescent Health and Medicine. Medication for adolescents and young adults with opioid use disorder. J Adolesc Health. 2021;68:632–6.CrossRef
26.
go back to reference Hadland SE, Park TW, Bagley SM. Stigma associated with medication treatment for young adults with opioid use disorder: a case series. Addict Sci Clin Pract. 2018;13:15.PubMedPubMedCentralCrossRef Hadland SE, Park TW, Bagley SM. Stigma associated with medication treatment for young adults with opioid use disorder: a case series. Addict Sci Clin Pract. 2018;13:15.PubMedPubMedCentralCrossRef
27.
go back to reference Giang V, Thulien M, McNeil R, Sedgemore K, Anderson H, Fast D. Opioid agonist therapy trajectories among street entrenched youth in the context of a public health crisis. SSM Popul Health. 2020;11:100609.PubMedPubMedCentralCrossRef Giang V, Thulien M, McNeil R, Sedgemore K, Anderson H, Fast D. Opioid agonist therapy trajectories among street entrenched youth in the context of a public health crisis. SSM Popul Health. 2020;11:100609.PubMedPubMedCentralCrossRef
28.
go back to reference Viera A, Bromberg DJ, Whittaker S, Refsland BM, Stanojlović M, Nyhan K, Altice FL. Adherence to and retention in medications for opioid use disorder among adolescents and young adults. Epidemiol Rev. 2020;42(1):41–56.PubMedPubMedCentralCrossRef Viera A, Bromberg DJ, Whittaker S, Refsland BM, Stanojlović M, Nyhan K, Altice FL. Adherence to and retention in medications for opioid use disorder among adolescents and young adults. Epidemiol Rev. 2020;42(1):41–56.PubMedPubMedCentralCrossRef
29.
go back to reference Feder KA, Krawczyk N, Saloner B. Medication-assisted treatment for adolescents in specialty treatment for opioid use disorder. J Adolesc Health. 2017;60:747–50.PubMedPubMedCentralCrossRef Feder KA, Krawczyk N, Saloner B. Medication-assisted treatment for adolescents in specialty treatment for opioid use disorder. J Adolesc Health. 2017;60:747–50.PubMedPubMedCentralCrossRef
30.
go back to reference Hadland SE, Wharam JF, Schuster MA, Zhang F, Samet JH, Larochelle MR. Trends in receipt of buprenorphine and naltrexone for opioid use disorder among adolescents and young adults, 2001–2014. JAMA Pediatr. 2017;171:747–55.PubMedPubMedCentralCrossRef Hadland SE, Wharam JF, Schuster MA, Zhang F, Samet JH, Larochelle MR. Trends in receipt of buprenorphine and naltrexone for opioid use disorder among adolescents and young adults, 2001–2014. JAMA Pediatr. 2017;171:747–55.PubMedPubMedCentralCrossRef
31.
go back to reference Neighbors CJ, Choi S, Healy S, Yerneni R, Sun T, Shapoval L. Age related medication for addiction treatment (mat) use for opioid use disorder among medicaid-insured patients in new york. Subst Abuse Treat Prev Policy. 2019;14:28.PubMedPubMedCentralCrossRef Neighbors CJ, Choi S, Healy S, Yerneni R, Sun T, Shapoval L. Age related medication for addiction treatment (mat) use for opioid use disorder among medicaid-insured patients in new york. Subst Abuse Treat Prev Policy. 2019;14:28.PubMedPubMedCentralCrossRef
32.
go back to reference Hill PL, Xavier C, Zhao B, Gan W, Jang K, Slaunwhite A, Buxton J. Health care utilization among a cohort of youth who experienced a fatal or non-fatal overdose in British Columbia, Canada, 2015–2017. Drug Alcohol Depend. 2021;212:108047. Hill PL, Xavier C, Zhao B, Gan W, Jang K, Slaunwhite A, Buxton J. Health care utilization among a cohort of youth who experienced a fatal or non-fatal overdose in British Columbia, Canada, 2015–2017. Drug Alcohol Depend. 2021;212:108047.
33.
go back to reference Bell E. Young persons in research: a call for the engagement of youth in mental health research. Am J Bioeth. 2015;15:28–30.PubMedCrossRef Bell E. Young persons in research: a call for the engagement of youth in mental health research. Am J Bioeth. 2015;15:28–30.PubMedCrossRef
34.
go back to reference Mawn L, Welsh P, Kirkpatrick L, Webster LA, Stain HJ. Getting it right! Enhancing youth involvement in mental health research. Health Expect. 2016;19:908–19.PubMedCrossRef Mawn L, Welsh P, Kirkpatrick L, Webster LA, Stain HJ. Getting it right! Enhancing youth involvement in mental health research. Health Expect. 2016;19:908–19.PubMedCrossRef
35.
go back to reference Hawke LD, Relihan J, Miller J, McCann E, Rong J, Darnay K, Docherty S, Chaim G, Henderson JL. Engaging youth in research planning, design and execution: practical recommendations for researchers. Health Expect. 2018;21:944–9.PubMedPubMedCentralCrossRef Hawke LD, Relihan J, Miller J, McCann E, Rong J, Darnay K, Docherty S, Chaim G, Henderson JL. Engaging youth in research planning, design and execution: practical recommendations for researchers. Health Expect. 2018;21:944–9.PubMedPubMedCentralCrossRef
36.
go back to reference Jurgens R. "Nothing about us without us". Greater, meaningful involvement of peopel who use drugs: A public health, ethical, and human rights imperative, international edition. . Toronto, Canada: Canadian HIV/AIDS Legal Network, International HIV/AIDS Alliance, Open Society; 2008. Jurgens R. "Nothing about us without us". Greater, meaningful involvement of peopel who use drugs: A public health, ethical, and human rights imperative, international edition. . Toronto, Canada: Canadian HIV/AIDS Legal Network, International HIV/AIDS Alliance, Open Society; 2008.
37.
go back to reference Brown G, Crawford S, Perry G-E, Byrne J, Dunne J, Reeders D, Corry A, Dicka J, Morgan H, Jones S. Achieving meaningful participation of people who use drugs and their peer organizations in a strategic research partnership. Harm Reduct J. 2019;16:37.PubMedPubMedCentralCrossRef Brown G, Crawford S, Perry G-E, Byrne J, Dunne J, Reeders D, Corry A, Dicka J, Morgan H, Jones S. Achieving meaningful participation of people who use drugs and their peer organizations in a strategic research partnership. Harm Reduct J. 2019;16:37.PubMedPubMedCentralCrossRef
38.
go back to reference Wallerstein NB, Duran B. Using community-based participatory research to address health disparities. Health Promot Pract. 2006;7:312–23.PubMedCrossRef Wallerstein NB, Duran B. Using community-based participatory research to address health disparities. Health Promot Pract. 2006;7:312–23.PubMedCrossRef
39.
go back to reference Minkler M, Nina W. Community-based participatory research for health: from process to outcomes. 2nd ed. San Francisco: Jossey-Bass; 2008. Minkler M, Nina W. Community-based participatory research for health: from process to outcomes. 2nd ed. San Francisco: Jossey-Bass; 2008.
40.
go back to reference Gustavsson SM, Andersson T. Patient involvement 2.0: Experience-based co-design supported by action research. Action Research. 2019;17:469–91.CrossRef Gustavsson SM, Andersson T. Patient involvement 2.0: Experience-based co-design supported by action research. Action Research. 2019;17:469–91.CrossRef
41.
go back to reference Chen E, Leos C, Kowitt SD, Moracco KE. Enhancing community-based participatory research through human-centered design strategies. Health Promot Pract. 2020;21:37–48.PubMedCrossRef Chen E, Leos C, Kowitt SD, Moracco KE. Enhancing community-based participatory research through human-centered design strategies. Health Promot Pract. 2020;21:37–48.PubMedCrossRef
42.
go back to reference Bate P, Robert G. Experience-based design: From redesigning the system around the patient to co-designing services with the patient. Qual Saf Health Care. 2006;15:307–10.PubMedPubMedCentralCrossRef Bate P, Robert G. Experience-based design: From redesigning the system around the patient to co-designing services with the patient. Qual Saf Health Care. 2006;15:307–10.PubMedPubMedCentralCrossRef
43.
go back to reference Greenhalgh T, Jackson C, Shaw S, Janamian T. Achieving research impact through co-creation in community-based health services: literature review and case study. Milbank Q. 2016;94:392–429.PubMedPubMedCentralCrossRef Greenhalgh T, Jackson C, Shaw S, Janamian T. Achieving research impact through co-creation in community-based health services: literature review and case study. Milbank Q. 2016;94:392–429.PubMedPubMedCentralCrossRef
44.
go back to reference Smith L, Rosenzweig L, Schmidt M. Best practices in the reporting of participatory action research: embracing both the forest and the trees 1ψ7. Couns Psychol. 2010;38:1115–38.CrossRef Smith L, Rosenzweig L, Schmidt M. Best practices in the reporting of participatory action research: embracing both the forest and the trees 1ψ7. Couns Psychol. 2010;38:1115–38.CrossRef
45.
go back to reference Damschroder LJ, Hagedorn HJ. A guiding framework and approach for implementation research in substance use disorders treatment. Psychol Addict Behav. 2011;25:194–205.PubMedCrossRef Damschroder LJ, Hagedorn HJ. A guiding framework and approach for implementation research in substance use disorders treatment. Psychol Addict Behav. 2011;25:194–205.PubMedCrossRef
50.
go back to reference McCune S, Pauly B, VanBoven S. Disrupting standard mode: A big picture story of family inclusion in substance use services. Victoria: Island Health, University of Victoria, Centre for Addictions Research of BC; 2017. McCune S, Pauly B, VanBoven S. Disrupting standard mode: A big picture story of family inclusion in substance use services. Victoria: Island Health, University of Victoria, Centre for Addictions Research of BC; 2017.
54.
go back to reference Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.CrossRef Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.CrossRef
55.
go back to reference Nowell LS, Norris JM, White DE, Moules NJ. Thematic analysis: Striving to meet the trustworthiness criteria. Int J Qual Methods. 2017;16:1609406917733847.CrossRef Nowell LS, Norris JM, White DE, Moules NJ. Thematic analysis: Striving to meet the trustworthiness criteria. Int J Qual Methods. 2017;16:1609406917733847.CrossRef
56.
go back to reference Marchand K, Beaumont S, Westfall J, MacDonald S, Harrison S, Marsh DC, Schechter MT, Oviedo-Joekes E. Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review. Subst Abuse Treat Prev Policy. 2019;14:37.PubMedPubMedCentralCrossRef Marchand K, Beaumont S, Westfall J, MacDonald S, Harrison S, Marsh DC, Schechter MT, Oviedo-Joekes E. Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review. Subst Abuse Treat Prev Policy. 2019;14:37.PubMedPubMedCentralCrossRef
57.
go back to reference Institute of Medicine (IOM). Crossing the quality chasm: A new health system for the 21st century. Washington: National Academy Press; 2001. Institute of Medicine (IOM). Crossing the quality chasm: A new health system for the 21st century. Washington: National Academy Press; 2001.
58.
59.
go back to reference Santana MJ, Manalili K, Jolley RJ, Zelinsky S, Quan H, Lu M. How to practice person-centred care: a conceptual framework. Health Expect. 2018;21:429–40.PubMedCrossRef Santana MJ, Manalili K, Jolley RJ, Zelinsky S, Quan H, Lu M. How to practice person-centred care: a conceptual framework. Health Expect. 2018;21:429–40.PubMedCrossRef
60.
go back to reference Marchand K, Oviedo-Joekes E. Prioritizing the patient in patient-centered addictions treatment. Addiction. 2017;112:466–7.PubMedCrossRef Marchand K, Oviedo-Joekes E. Prioritizing the patient in patient-centered addictions treatment. Addiction. 2017;112:466–7.PubMedCrossRef
61.
go back to reference Blanco C, Wiley TRA, Lloyd JJ, Lopez MF, Volkow ND. America’s opioid crisis: the need for an integrated public health approach. Transl Psychiatry. 2020;10:167.PubMedPubMedCentralCrossRef Blanco C, Wiley TRA, Lloyd JJ, Lopez MF, Volkow ND. America’s opioid crisis: the need for an integrated public health approach. Transl Psychiatry. 2020;10:167.PubMedPubMedCentralCrossRef
62.
go back to reference Marchand K, Foreman J, MacDonald S, Harrison S, Schechter MT, Oviedo-Joekes E. Building healthcare provider relationships for patient-centered care: a qualitative study of the experiences of people receiving injectable opioid agonist treatment. Subst Abuse Treat Prev Policy. 2020;15:7.PubMedPubMedCentralCrossRef Marchand K, Foreman J, MacDonald S, Harrison S, Schechter MT, Oviedo-Joekes E. Building healthcare provider relationships for patient-centered care: a qualitative study of the experiences of people receiving injectable opioid agonist treatment. Subst Abuse Treat Prev Policy. 2020;15:7.PubMedPubMedCentralCrossRef
63.
go back to reference Zuckermann AME, Qian W, Battista K, Jiang Y, de Groh M, Leatherdale ST. Factors influencing the non-medical use of prescription opioids among youth: results from the compass study. Journal of Substance Use. 2020;25:507–14.CrossRef Zuckermann AME, Qian W, Battista K, Jiang Y, de Groh M, Leatherdale ST. Factors influencing the non-medical use of prescription opioids among youth: results from the compass study. Journal of Substance Use. 2020;25:507–14.CrossRef
64.
go back to reference Guarino H, Mateu-Gelabert P, Teubl J, Goodbody E. Young adults’ opioid use trajectories: from nonmedical prescription opioid use to heroin, drug injection, drug treatment and overdose. Addict Behav. 2018;86:118–23.PubMedPubMedCentralCrossRef Guarino H, Mateu-Gelabert P, Teubl J, Goodbody E. Young adults’ opioid use trajectories: from nonmedical prescription opioid use to heroin, drug injection, drug treatment and overdose. Addict Behav. 2018;86:118–23.PubMedPubMedCentralCrossRef
Metadata
Title
Improving Treatment Together: a protocol for a multi-phase, community-based participatory, and co-design project to improve youth opioid treatment service experiences in British Columbia
Authors
Kirsten Marchand
Corinne Tallon
Christina Katan
Jill Fairbank
Oonagh Fogarty
Katrina Marie Pellatt
Roxanne Turuba
Steve Mathias
Skye Barbic
Publication date
01-12-2021
Publisher
BioMed Central
Keywords
Opioids
Opioids
Published in
Addiction Science & Clinical Practice / Issue 1/2021
Electronic ISSN: 1940-0640
DOI
https://doi.org/10.1186/s13722-021-00261-7

Other articles of this Issue 1/2021

Addiction Science & Clinical Practice 1/2021 Go to the issue